As the end of 2024 is approaching, the programs of the important international ophthalmology conferences to be held in 2025 have begun to be announced.
Eye Drop Company Faces FDA Scrutiny Again Over Unapproved ProductsSep 19, 2024The FDA has issued a warning letter to the Regenerative Processing Plant, manufacturer of Regener-Eyes Pro and Lite eye drops, for marketing unapproved products claiming to treat dry eyes.
Maestro®: The Sinusoidal IOLSep 18, 2024VSY Biotechnology introduced the Maestro® Sinusoidal IOL at ESCRS 2024, featuring SVT. This innovative trifocal lens enhances visual acuity, contrast sensitivity, and light transmission, offering a cutting-edge solution for presbyopia management.
Blood Pressure Variability Linked to Accelerated Vision Loss in GlaucomaNov 20, 2024A study led by researchers at the University of California, San Diego, reveals that long-term variability in blood pressure is associated with an accelerated decline in peripheral vision caused by glaucoma progression.
Nicotine's Potential in Myopia Control: Animal Research FindingsSep 27, 2024Researchers led by Dr. Kate Thomson from the University of Canberra have found that nicotine, when administered either as an intravitreal injection or topical eye drop, significantly inhibited the development of FDM and LIM in chicks.
Lamprey's Eye Disease: Separating Fact from FictionSep 30, 2024Lamprey Eye Disease, also known as "Lamprey Disease," is a hoax that has been circulating on the internet for several years. The hoax claims that a parasitic fish known as the lamprey is responsible for a disease that can cause blindness in humans.